Skip to main content
Erschienen in:

11.01.2017

Endotherapy in case of relapse of neoplastic Barrett’s esophagus after successful initial endoscopic resection

verfasst von: Sébastien Godat, Fabrice Caillol, Aurélie Autret, Erwan Bories, Christian Pesenti, Jean Philippe Ratone, Chiara De Cassan, Flora Poizat, Marc Giovannini

Erschienen in: Surgical Endoscopy | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Endotherapy in cases of neoplastic Barrett esophagus (BE) relapse after successful initial endoscopic management is commonly accepted, but few studies analyze this topic and also take into account the metachronous lesions.

Aims

To evaluate the efficiency of endotherapy in the case of neoplastic BE relapse after successful complete endoscopic eradication of neoplastic BE and metaplastic BE.

Methods

Retrospective review of medical records was collected in a computerized and prospective manner between 2000 and 2015, in a single tertiary care center. Recurrence was defined by histological presence of high-grade dysplasia or superficial adenocarcinoma at least 6 months after the end of successful initial endotherapy.

Results

Eighteen patients were assessed (1F/17 M). Delay between initial treatment and relapse was 16.6 months (range 6–33). Endotherapy for relapse obtained a sustained and complete remission for 8/18 (44%) patients, with an average endoscopic follow-up of 28 months. The complication rate of endotherapy was 6%. Surgical management was required in 33% (2 pT2N0M0, 2 pTisN0M0, 1 pTm2N0M0 and 1 pTm3N0M0) and salvage radiochemotherapy in 17% (3/18). One patient treated by 6 sessions of ER was considered as a failure given the multiple sessions of endotherapy. Multivariate analysis showed that length of BE (>5 cm), late stenosis adverse events and the quality of vertical margin during initial ER are predictive factors for disease-free survival (p value < 0.01, Hazard Ratio up to 0.076).

Conclusion

Endotherapy could be a treatment for management of neoplastic BE relapse, but should be carefully used, with strict follow-up.
Literatur
1.
Zurück zum Zitat Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143(2):336–346CrossRefPubMedPubMedCentral Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143(2):336–346CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Van Vilsteren FG, Pouw RE, Seewald S et al (2011) Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 60(6):765–773CrossRefPubMed Van Vilsteren FG, Pouw RE, Seewald S et al (2011) Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 60(6):765–773CrossRefPubMed
3.
Zurück zum Zitat Alvarez Herrero L, van Vilsteren FG, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 73(4):682–690CrossRefPubMed Alvarez Herrero L, van Vilsteren FG, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 73(4):682–690CrossRefPubMed
4.
Zurück zum Zitat Chennat J, Konda VJ, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma–an American single-center experience. Am J Gastroenterol 104(11):2684–2692CrossRefPubMed Chennat J, Konda VJ, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma–an American single-center experience. Am J Gastroenterol 104(11):2684–2692CrossRefPubMed
5.
Zurück zum Zitat Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed
6.
Zurück zum Zitat Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 107(6):850–862CrossRefPubMedPubMedCentral Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 107(6):850–862CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Höbel S, Dautel P, Baumbach R et al (2015) Single center experience of endoscopic submucosal dissection (ESD) in early Barrett´s adenocarcinoma. Surg Endosc 29(6):1591–1597CrossRefPubMed Höbel S, Dautel P, Baumbach R et al (2015) Single center experience of endoscopic submucosal dissection (ESD) in early Barrett´s adenocarcinoma. Surg Endosc 29(6):1591–1597CrossRefPubMed
8.
Zurück zum Zitat Kim HP, Bulsiewicz WJ, Cotton CC et al (2012) Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc 76(4):733–739CrossRefPubMedPubMedCentral Kim HP, Bulsiewicz WJ, Cotton CC et al (2012) Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc 76(4):733–739CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Haidry RJ, Butt MA, Dunn JM et al (2014) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut pii: gutjnl-2014-308501 Haidry RJ, Butt MA, Dunn JM et al (2014) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut pii: gutjnl-2014-308501
10.
Zurück zum Zitat Caillol F, Bories E, Pesenti C et al (2012) Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol 36(4):371–377CrossRefPubMed Caillol F, Bories E, Pesenti C et al (2012) Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol 36(4):371–377CrossRefPubMed
11.
Zurück zum Zitat Blevins CH, Iyer PG (2015) Endoscopic therapy for Barrett’s oesophagus. Best Pract Res Clin Gastroenterol 29(1):167–177CrossRefPubMed Blevins CH, Iyer PG (2015) Endoscopic therapy for Barrett’s oesophagus. Best Pract Res Clin Gastroenterol 29(1):167–177CrossRefPubMed
12.
Zurück zum Zitat Anders M, Bähr C, El-Masry MA et al (2014) Long-term recurrence of neoplasia and Barrett’s epithelium after complete endoscopic resection. Gut 63(10):1535–1543CrossRefPubMed Anders M, Bähr C, El-Masry MA et al (2014) Long-term recurrence of neoplasia and Barrett’s epithelium after complete endoscopic resection. Gut 63(10):1535–1543CrossRefPubMed
13.
Zurück zum Zitat Gupta M, Iyer PG, Lutzke L et al (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 145(1):79-86.e1 Gupta M, Iyer PG, Lutzke L et al (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 145(1):79-86.e1
14.
Zurück zum Zitat Giovannini M, Bories E, Pesenti C et al (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9):782–787CrossRefPubMed Giovannini M, Bories E, Pesenti C et al (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9):782–787CrossRefPubMed
15.
Zurück zum Zitat Pech O, May A, Manner H et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652-660.e1 Pech O, May A, Manner H et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652-660.e1
16.
Zurück zum Zitat Neuhaus H, Terheggen G, Rutz EM et al (2012) Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus. Endoscopy 44(12):1105–1113CrossRefPubMed Neuhaus H, Terheggen G, Rutz EM et al (2012) Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus. Endoscopy 44(12):1105–1113CrossRefPubMed
17.
Zurück zum Zitat Pouw RE, Wirths K, Eisendrath P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8(1):23–29CrossRefPubMed Pouw RE, Wirths K, Eisendrath P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8(1):23–29CrossRefPubMed
18.
Zurück zum Zitat Phoa KN, Pouw RE, van Vilsteren FG et al (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145(1):96–104CrossRefPubMed Phoa KN, Pouw RE, van Vilsteren FG et al (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145(1):96–104CrossRefPubMed
19.
Zurück zum Zitat Kagemoto K, Oka S, Tanaka S et al (2014) Clinical outcomes of endoscopic submucosal dissection for superficial Barrett’s adenocarcinoma. Gastrointest Endosc 80(2):239–245CrossRefPubMed Kagemoto K, Oka S, Tanaka S et al (2014) Clinical outcomes of endoscopic submucosal dissection for superficial Barrett’s adenocarcinoma. Gastrointest Endosc 80(2):239–245CrossRefPubMed
20.
Zurück zum Zitat Haidry RJ, Butt MA, Dunn J et al (2013) Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry. World J Gastroenterol 19(36):6011–6019CrossRefPubMedPubMedCentral Haidry RJ, Butt MA, Dunn J et al (2013) Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry. World J Gastroenterol 19(36):6011–6019CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nozaki I, Kato K, Igaki H et al (2015) Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study. Surg Endosc 29:3519–3526CrossRefPubMedPubMedCentral Nozaki I, Kato K, Igaki H et al (2015) Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study. Surg Endosc 29:3519–3526CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Filip B, Scarpa M, Cavallin F et al (2015) Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6):787–794CrossRefPubMed Filip B, Scarpa M, Cavallin F et al (2015) Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6):787–794CrossRefPubMed
23.
Zurück zum Zitat Wolfsen HC, Hemminger LL, DeVault KR (2004) Recurrent Barrett’s esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol 25(4):18CrossRef Wolfsen HC, Hemminger LL, DeVault KR (2004) Recurrent Barrett’s esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol 25(4):18CrossRef
24.
Zurück zum Zitat Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206CrossRefPubMed Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206CrossRefPubMed
Metadaten
Titel
Endotherapy in case of relapse of neoplastic Barrett’s esophagus after successful initial endoscopic resection
verfasst von
Sébastien Godat
Fabrice Caillol
Aurélie Autret
Erwan Bories
Christian Pesenti
Jean Philippe Ratone
Chiara De Cassan
Flora Poizat
Marc Giovannini
Publikationsdatum
11.01.2017
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 9/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5409-5

Neu im Fachgebiet Chirurgie

Antibiotika bei Erwachsenen mit Appendizitis oft ausreichend

Bei etwa zwei Drittel aller Erwachsenen mit akuter Appendizitis könnte eine antibiotische Behandlung ausreichen, wie eine Metaanalyse nahelegt. Die Komplikationsrate war insgesamt gering, auch wenn letztlich doch eine Op. fällig wurde.

Katheterablation bei Vorhofflimmern: Ist frühe Intervention von Vorteil?

Bei Patienten mit Vorhofflimmern scheinen die Therapieergebnisse bezüglich Rezidivfreiheit bei frühzeitiger Katheterablation besser zu sein als bei später erfolgter Ablation. Dafür sprechen Ergebnisse einer aktuellen Registeranalyse. 

Beugt Tranexamsäure schweren Blutungen auch in der Allgemeinchirurgie vor?

Ergebnisse einer Subgruppenanalyse der POISE-3-Studie sprechen dafür, dass eine Prophylaxe mit Tranexamsäure auch bei allgemeinchirurgischen Eingriffen das Risiko für schwere Blutungen senkt.

Höhere Anspannung vor der Op. führt offenbar zu besserem Ergebnis

Ein gewisses Maß an Stress zu Beginn der Op. wirkt sich möglicherweise positiv auf das Gelingen aus, so ein Team aus Boston. Die Komplikationsrate ging unter diesen Umständen signifikant zurück.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.